Lack of significant toxicity after mirtazapine overdose: A five-year review of cases admitted to a regional toxicology unit

References

• de Boer TH, Maura G, Raiteri M, de Vos CJ, Wieringa J, Pinder RM. Neurochemical and autonomic pharmacological profiles of the 6-aza-analogue of mianserin, Org 3770 and its enantiomers. Neuropharmacology 1988; 27: 399–408
   PubMed Web of Science ®Google Scholar
• Davis R, Wilde MI. Mirtazapine: a review of its pharmacology and therapeutic potential in the management of major depression. CNS Drugs 1996; 5: 389–402
   PubMed Web of Science ®Google Scholar
• Stimmel GL, Dopheide JA, Stahl SM. Mirtazapine: an antidepressant with noradrenergic and specific serotonergic effects. Pharmacotherapy 1997; 17: 10–21
   PubMed Web of Science ®Google Scholar
• Holm KJ, Markham A. Mirtazapine: a review of its use in major depression. Drugs 1999; 57: 607–631
   PubMed Web of Science ®Google Scholar
• Kasper S, Zivkov M, Roes KC, Pols AG. Pharmacological treatment of severely depressed patients: a meta-analysis comparing efficacy of mirtazapine and amitriptyline. Eur Neuropsychopharmacol 1997; 7: 115–124
   PubMed Web of Science ®Google Scholar
• Amini H, Aghayan S, Jalili SA, Akhondzadeh S, Yahyazadeh O, Pakravan-Nejad M. Comparison of mirtazapine and fluoxetine in the treatment of major depressive disorder: a double-blind, randomized trial. J Clin Pharm Ther 2005; 30: 133–138
   PubMed Web of Science ®Google Scholar
• Schatzberg AF, Kremer C, Rodrigues HE, Murphy GM, Jr, Mirtazapine vs. Paroxetine Study Group. Double-blind, randomized comparison of mirtazapine and paroxetine in elderly depressed patients. Am J Geriatr Psychiatry 2002; 10: 541–550
   PubMed Web of Science ®Google Scholar
• Konstantinidis A, Stastny J, Ptak-Butta J, Hilger E, Winkler D, Barnas C, Neumeister A, Kasper S. Intravenous mirtazapine in the treatment of depressed inpatients. Eur Neuropsychopharmacol 2002; 12: 57–60
   PubMed Web of Science ®Google Scholar
• Biswas PN, Wilton LV, Shakir SA. The pharmacovigilance of mirtazapine: results of a prescription event monitoring study on 13554 patients in England. J Psychopharmacol 2003; 17: 121–126
   PubMed Web of Science ®Google Scholar
• Luo S, Michler K, Johnston P, Macfarlane PW. A comparison of commonly used QT correction formulae: the effect of heart rate on the QTc of normal ECGs. J Electrocardiol 2004; 37(Suppl)81–90
   PubMedGoogle Scholar
• Winokur A, Sateia MJ, Hayes JB, Bayles-Dazet W, MacDonald MM, Gary KA. Acute effects of mirtazapine on sleep continuity and sleep architecture in depressed patients: a pilot study. Biol Psychiatry 2000; 48: 75–78
   PubMed Web of Science ®Google Scholar
• Whyte IM, Dawson AH, Buckley NA. Relative toxicity of venlafaxine and selective serotonin reuptake inhibitors in overdose compared to tricyclic antidepressants. QJM 2003; 96: 369–374
   PubMed Web of Science ®Google Scholar
• Bailey B, Buckley NA, Amre DK. A meta-analysis of prognostic indicators to predict seizures, arrhythmias or death after tricyclic antidepressant overdose. J Toxicol Clin Toxicol 2004; 42: 877–888
   PubMed Web of Science ®Google Scholar
• http://medicines.mhra.gov.uk/ourwork/monitorsafequalmed/;safetymessages/SSRI61204ddl.pdf, MHRA recent advice on SSRIs
   Google Scholar
• Combes A, Peytavin G, Theron D. Conduction disturbances associated with venlafaxine. Ann Intern Med 2001; 134: 166–167
   PubMed Web of Science ®Google Scholar
• Peano C, Leikin JB, Hanashiro PK. Seizures, ventricular tachycardia, and rhabdomyolysis as a result of ingestion of venlafaxine and lamotrigine. Ann Emerg Med 1997; 30: 704–708
   PubMed Web of Science ®Google Scholar
• Kelly CA, Dhaun N, Laing WJ, Strachan FE, Good AM, Bateman DN. Comparative toxicity of citalopram and the newer antidepressants after overdose. J Toxicol Clin Toxicol 2004; 42: 67–71
   PubMed Web of Science ®Google Scholar
• Khalifa M, Daleau P, Turgeon AJ. Mechanism of sodium channel block by venlafaxine in guinea pig ventricular myocytes. J Pharmacol Exp Ther 1999; 291: 280–284
   PubMed Web of Science ®Google Scholar
• Strickberger SA, Ip J, Saksena S, Curry K, Bahnson TD, Ziegler PD. Relationship between atrial tachyarrhythmias and symptoms. Heart Rhythm 2005; 2: 125–131
   PubMed Web of Science ®Google Scholar
• Hoes MJ, Zeijpveld JH. First report of mirtazapine overdose. Int Clin Psychopharmacol 1996; 11: 147
   PubMed Web of Science ®Google Scholar
• Langford NJ, Ferner RE, Patel H, Munyame C, Hamlyn AN. Mirtazepine overdose and miosis. J Toxicol Clin Toxicol 2003; 41: 1037–1038
   PubMed Web of Science ®Google Scholar
• Holzbach R, Jahn H, Pajonk FG, Mahne C. Suicide attempts with mirtazapine overdose without complications. Biol Psychiatry 1998; 44: 925–926
   PubMed Web of Science ®Google Scholar
• Velazquez C, Carlson A, Stokes KA, Leikin JB. Relative safety of mirtazapine overdose. Vet Hum Toxicol 2001; 43: 342–344
   PubMedGoogle Scholar
• Raja M, Azzoni A. Mirtazapine overdose with benign outcome. Eur Psychiatry 2002; 17: 107
   PubMed Web of Science ®Google Scholar
• Garlipp P, Bruggemann BR, Machleidt W. A non-fatal mirtazapine overdose in a suicide attempt. Aust N Z J Psychiatry 2003; 37: 244–245
   PubMed Web of Science ®Google Scholar
• Gerritsen AW. Safety in overdose of mirtazapine: a case report. J Clin Psychiatry 1997; 58: 271
   PubMed Web of Science ®Google Scholar
• Retz W, Maier S, Maris F, Rosler M. Non-fatal mirtazapine overdose. Int Clin Psychopharmacol 1998; 13: 277–279
   PubMed Web of Science ®Google Scholar
• Kuliwaba A. Non-lethal mirtazapine overdose with rhabdomyolysis. Aust N Z J Psychiatry 2005; 39: 312–313
   PubMed Web of Science ®Google Scholar
• Khandat AB, Nurnberger JI, Jr, Shekhar A. Possible mirtazapine-induced rhabdomyolysis. Ann Pharmacother 2004; 38: 1321
   PubMed Web of Science ®Google Scholar
• Wenzel S, Aderjan R, Mattern R, Pedal I, Skopp G. Tissue distribution of mirtazapine and desmethylmirtazapine in a case of mirtazapine poisoning. Forensic Sci Int 2006; 156: 229–236
   PubMed Web of Science ®Google Scholar
• Ciuna A, Andretta M, Corbari L, Levi D, Mirandola M, Sorio A, Barbui C. Are we going to increase the use of antidepressants up to that of benzodiazepines?. Eur J Clin Pharmacol 2004; 60: 629–634
   PubMed Web of Science ®Google Scholar